![]() ![]() When it comes to addressing the first challenge of treating patients with minimal contact, “one of our current portfolio companies, EndoWays, has attracted attention with its first-of-its-kind disposable robotic system for the cath lab to navigate through tortuous blood vessels,” Policker said. With the first wave of COVID-19, Policker said that “it became clear that better solutions were needed to treat patients with minimal contact by medical teams” and the need to “delay…the point in time in which COVID-19 patients require a respirator,” “We are currently working on several projects addressing these needs, including a collaboration focused on respiration with Sheba Medical Center,” he said. “Our focus as an incubator is on developing multi-disciplinary solutions to complex unmet clinical needs,” he said.Īs the world continues to grapple with the coronavirus pandemic, MEDX Xelerator has put a strong focus on helping in the fight against the deadly illness. Israeli MedTech incubator MEDX Xelerator is putting its all into developing multi-disciplinary solutions to complex unmet clinical needs.ĬEO of MEDX Xelerator Shai Policker told IsraelNewsStand that the MedTech incubator, under the auspices of the Israel Innovation Authority (IIA), formed as a partnership between Boston Scientific, MEDX Ventures, Intellectual Ventures and Sheba Medical Center. Facilitate connects and networking for BIG applicants.As the world continues to grapple with the coronavirus pandemic, Israel’s MEDX Xelerator has put a strong focus on helping in the fight against the deadly illness, the incubator’s CEO tells IsraelNewsStand By ILANIT CHERNICK.Mentoring provided for areas including but not limited to technical, business, IP, legal, regulatory etc. Mentor and handhold prospective BIG applicants and assist them for application.Orient Innovators and Entrepreneurs on the eligibility and aim of BIG schemes.Support Provided by IITM HTIC MedTech Incubator as a BIG Associate Partner ![]() Expert Selection Committee (ESC) will decide the final cutoff of marks and recommend the proposals for BIG funding.The proposal will be scored on a scale of 100. The recommended applicants are then called for F2F presentations before Technical Evaluation Panel (TEP).The PSC recommended proposals are then reviewed Online by subject experts.Preliminary Selection Committee (PSC) screens the proposals for scheme fit, adequacy of details, plagiarism.All eligible applications go thorough following steps: Eligibility criteria for start-ups under BIG has been revised.Scientists, Faculty, Research Scholars, Graduates in any discipline incubating/ intend to incubate at a BioIncubator.Start-up age allowed for a registered company/ LLP incorporated under BIG w.e.f 1st Aug 2020: 5 years.Under BIG scheme, BIRAC provides grant-in-aid of upto INR 50 lakhs (approx USD 75,000) for a period of 18 months.īIG scheme supports innovation under Healthcare, Lifesciences, Diagnostics, Medical Devices, Drugs, Vaccines, Drug Formulations and delivery systems, Industrial Biotechnology, Agriculture, Secondary agriculture, Waste Management, Sanitation, Clean Energy and related areas.īIRAC invites proposals from Biotech Start-ups and Individual Entrepreneurs with innovative idea having potential for commercialization. BIG supports individual entrepreneurs/ start-ups from ideation to Proof of Concept (PoC). The ideas should have clear potential to translate into commercial products/technologies. IIT Madras-HTIC MedTech Incubator is a BIRAC’s Associate BIG Partner.īIG (Biotechnology Ignition Grant) is a flagship scheme of BIRAC which recognizes and invests in innovative ideas in the biotech sector.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |